MACROGENICS, INC. Restructuring Reserve
MACROGENICS, INC. (MGNX) had Restructuring Reserve of $0 as of 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2018-05-07
- 2018-03-31: Restructuring Reserve $0.00.
- 2017-12-31: Restructuring Reserve $298.00K.
- 2017-09-30: Restructuring Reserve $715.00K.
- 2017-06-30: Restructuring Reserve $1.12M.
| Period end | Restructuring Reserve |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-07 |
| 2017-12-31 | $298.00K 10-Q · filed 2018-05-07 |
| 2017-09-30 | $715.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.12M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $1.51M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $1.89M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |